+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Uveitis"

Uveitis Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Uveitis Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • February 2024
  • 204 Pages
  • Global
From
Uveitis Patient Pool Analysis, Market Size and Market Forecast APAC - 2034 - Product Thumbnail Image

Uveitis Patient Pool Analysis, Market Size and Market Forecast APAC - 2034

  • Report
  • February 2024
  • 120 Pages
  • Asia Pacific
From
From
Retinal Biologics Global Market Report 2024 - Product Thumbnail Image

Retinal Biologics Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Uveitis Treatment: Global Strategic Business Report - Product Thumbnail Image

Uveitis Treatment: Global Strategic Business Report

  • Report
  • April 2024
  • 194 Pages
  • Global
From
From
Ophthalmic Medical Lasers Global Market Report 2024 - Product Thumbnail Image

Ophthalmic Medical Lasers Global Market Report 2024

  • Report
  • November 2023
  • 250 Pages
  • Global
From
From
From
From
From
From
From
From
From
Loading Indicator

Uveitis is a medical condition that affects the uvea, the middle layer of the eye. It is characterized by inflammation of the uvea, which can lead to vision loss and other complications. In the context of optical, uveitis is a major cause of vision loss and can be treated with a variety of treatments, including topical and systemic medications, laser treatments, and surgery. Uveitis is a growing market in the optical industry, as it is a common cause of vision loss and can be treated with a variety of treatments. Companies in the uveitis market include Bausch + Lomb, Novartis, Allergan, and Santen Pharmaceuticals. These companies offer a range of treatments for uveitis, including topical and systemic medications, laser treatments, and surgery. Show Less Read more